PTEN and PTEN hamartoma tumor syndrome: It also supports reevaluation of patients who test negative by DNA testing alone but with a clinical diagnosis of PHTS/CS with subsequent RNA testing to identify and clinically interpret previously undetected deep intronic PTEN variants.